Saturday, December 12, 2020 9:06:53 PM
This looks like the most promising upside #Biotech #Covid19 drug trial stock I know of right of right now.
I found this stock earlier in an email link to a seeking alpha article, sent it to one of my buddies, Drugman... and he got in and reminded me later to look at it again. Then I researched the Bucillaime and RA applications (I have RA...and I have bio-chemical Engineering back ground/degrees... so I know one hell of lot about it and the biochemistry and drugs..)
But I had not seen that pdf, so I may be loading a few boats this week before we make new 2020 highs.
This actually could go to $10/share if what I read in that paper pans out in Covid19 trials. If not, it is still about to be a $2 to $3 stock just based on the reduced Cytokine storm life laving potential.
But if it can stop serious infections by cripple the virus's ability to infect cells, I do not think the bulk of the medical Biotech community even has this on their radar yet.
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
